Australia's largest stock trading and investment forum Australia's #1 stock forum

APT

Click for more information

0.00%

$66.47 afterpay limited

Mate, or miss.... the drop is market related and not stock...

First 556 Last

Share
Profile

Follow
Revro

2,681 Posts.

299

03/03/20

16:29

Post #: 43283699
Share

Originally posted by JCoure: ↑

whoa, not yet, only if Nicole Rose is resigned or is sacked on Monday, and only if the new Dutton regime (Nicole Rose was a Michael Keenan appointee) has an AUSTRAC CEO who comes after the BNPL corporates like APT?

A new AUSTRAC might pursue APT harder but it will take time IMHO.

AUSTRAC implosion is better news for Westpac, along with TAH and CBA, the only ones affected so far from the Rose’s AUSTRAC?

I think the compliance is a real risk for APT and the risk got bigger with tthe New Corp articles into the AUSTRAC Investigation and the Nicole Rose lack of Tertiary qualification and the CV which News Corp argues is highly embellished and the Nicole is under qualified.

The uncertainty and risks for APT are already out there though with an over 9% drop. if the news about AUSTRAC was known and the news articles afore known, it will not go down another, but if not, it could be worse?

Expand

Mate, or miss.... the drop is market related and not stock related.

You are misguided, or attempting to misguide.

APT Price at posting: $34.66 Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

There are more pages in this discussion • 20 more messages in this thread...

First 556 Last

Add APT (ASX) to my watchlist